BROKERAGESCLSA on pharma: Trump’s 25% tariff adds uncertainty; firms may hike prices if generics included Jul 31, 2025
BROKERAGESCLSA maintains high-conviction buy on Indus Towers, expects 55% upside amid steady tenancy base Jul 31, 2025
BROKERAGESInterGlobe Aviation share: CITI maintains buy, sees 14% upside despite Q1 miss on weak yields Jul 31, 2025
BROKERAGESM&M share: CITI maintains buy, sees 15% upside on strong rural outlook and upcoming UV launches Jul 31, 2025
BROKERAGESCITI maintains sell on Navin Fluorine; sees 9% downside citing limited upside after sharp rally Jul 31, 2025
STOCK MARKETTrump tariff impact: CLSA flags ‘hit to safe haven’ status; brokerages see export, GDP risks for India Jul 31, 2025
BLOGFuture-Proofing Your Business: The Importance of Agility in Building an Adaptive Business Jul 30, 2025